Virus | Recipient cells | Trial 1 | Trial 2 | Trial 3 | Trial 4 | Ave ± Std |
---|
IU/ml* | IU/ml | IU/ml | IU/ml | IU/ml | Relative infectivity** |
---|
XMRV | 293/pcDNA3 | 2.5 X 106 | 2.9 X 106 | 1.7 X 106 | 2.9 X 106 | 2.5 ± 0.52 X 106 | 1 ± 0 |
 | 293/hA3B | 2.2 X 106 | 2.3 X 106 | 2.5 X 106 | 4.3 X 106 | 2.8 ± 0.97 X 106 | 1.17 ± 0.365 |
MX | 293/pcDNA3 | 6.5 X 106 | 6.9 X 106 | 5.1 X 106 | 8.3 X 106 | 6.7 ± 1.3 X 106 | 2.73 ± 0.231 |
 | 293/hA3B | 6.9 X 106 | 9.0 X 106 | 3.6 X 106 | 8.2 X 106 | 6.9 ± 2.4 X 106 | 2.72 ± 0.462 |
- The 293 cells transfected with the plasmid encoding HA-tagged hA3B plasmids (293/hA3B) or control plasmids (293/pcDNA3) were selected by G418 and were used as recipient cells for infectivity assay. The recipient cells were infected with XMRV or MX viruses that were produced from the infected 293 T cells. *The infectious units (IU) were measured from the number of infectious centers that was normalized by the amount of Capsid in viruses and IU per ml was shown. **The relative infectivity to the 293/pcDNA3 infected with XMRV viruses was shown.